Acanthosis nigricans: Clinical predictor of abnormal glucose tolerance in Asian women with polycystic ovary syndrome

References

• Conway G. Polycystic ovary syndrome: clinical aspects. Baillieres Clin Endocrinol Metab 1996; 10: 263–279
   PubMedGoogle Scholar
• Franks S. Polycystic ovary syndrome. N Engl J Med 1995; 333: 853–861
   PubMed Web of Science ®Google Scholar
• Knochenhauer E S, Key T J, Kahsar-Miller M, Waggoner W, Boots L R, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998; 83: 3078–3082
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Kouli C R, Bergiele A T, Filandra F A, Tsianateli T C, Spina G G, Zapanti E D, Bartzis M I. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84: 4006–4011
   PubMed Web of Science ®Google Scholar
• Dunaif A. Insulin resistance and polycystic ovary syndrome: mechanisms and implications for pathogenesis. Endocr Rev 1997; 18: 774–800
   PubMed Web of Science ®Google Scholar
• Kahn C R, Flier J S, Bar S S, Archer J A, Gorden P, Martin M M, Roth J. The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med 1976; 294: 739–745
   PubMed Web of Science ®Google Scholar
• Burghen G A, Givens J R, Kitabchi A E. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 1980; 50: 113–116
   PubMed Web of Science ®Google Scholar
• Chang R J, Nakamura R M, Judd H L, Kaplan S A. Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab 1983; 57: 356–359
   PubMed Web of Science ®Google Scholar
• Shoupe D, Kumar D D, Lobo R A. Insulin resistance in polycystic ovary syndrome. Am J Obstet Gynecol 1983; 47: 588–592
   Google Scholar
• Pasquali R, Venturoli S, Paradisi R, Capelli M, Parenti M, Melchionda N. Insulin and C-peptide levels in obese patients with polycystic ovaries. Horm Metab Res 1982; 14: 284–287
   PubMed Web of Science ®Google Scholar
• Dunaif A, Segal K R, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989; 38: 1165–1174
   PubMed Web of Science ®Google Scholar
• Dunaif A, Segal K R, Shelley D RR, Green G, Dobrjansky A, Licholai T. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 1992; 41: 1257–1266
   PubMed Web of Science ®Google Scholar
• Warram J H, Martin B C, Krolewski A S, Soeldner J S, Kahn C R. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 1990; 113: 909–915
   PubMed Web of Science ®Google Scholar
• Reaven G M. Role of insulin resistance in human disease. Diabetes 1998; 37: 1595–1607
   Google Scholar
• Lillioja S, Mott D, Spraul M, Ferraro R, Foley J E, Ravussin E, Knowler W C, Bennett P H, Bogardus C. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 1993; 329: 1988–1992
   PubMed Web of Science ®Google Scholar
• Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab 1987; 65: 499–507
   PubMed Web of Science ®Google Scholar
• Legro R S, Kunselman A R, Dodson W C, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinal Metab 1999; 84: 165–169
   PubMed Web of Science ®Google Scholar
• Ehrmann D A, Barnes R B, Rosenfield R L, Cavaghan M K, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999; 22: 141–146
   PubMed Web of Science ®Google Scholar
• Weerakiet S, Srisombut C, Bunnag P, Sangtong S, Chuangsoongnoen N, Rojanasakul A. Prevalence of type 2 DM and impaired glucose tolerance in Asian women with polycystic ovary syndrome. Int J Gynaecol Obstet 2001; 75: 177–184
   PubMed Web of Science ®Google Scholar
• Katz A S, Goff D C, Feldman S R. Acanthosis nigricans in obese patients: presentations and implications for prevention of atherosclerotic vascular disease. Dermatol Online J 2000; 6: 1
   Google Scholar
• Flier J S, Eastman R C, Minaker K L, Matteson D, Rowe J W. Acanthosis nigricans in obese women with hyperandrogenism. Characterization of an insulin-resistant state distinct from the type A and B syndromes. Diabetes 1985; 34: 101–107
   PubMed Web of Science ®Google Scholar
• Wijeyaratne C N, Balen A H, Barth J H, Belchetz P A. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?. Clin Endocrinol (Oxf) 2002; 5: 343–345
   Google Scholar
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41–47
   PubMed Web of Science ®Google Scholar
• Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen M R, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683–689
   PubMed Web of Science ®Google Scholar
• World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. WHO, Geneva 1999, Part I. Diagnosis and classification of diabetes mellitus
   Google Scholar
• Eugelgan M M, Narayan K MU, Herman W H. Screening for type 2 diabetes. Diabetes Care 2000; 23: 1563–1580
   Google Scholar
• Hershlag A, Peterson C M. Endocrine disorder. Novak's gynecology. 13th ed, J S Berek. Lippincott Williams & Wilkins, Philadelphia, PA 2002; 871–930
   Google Scholar
• Moran L, Norman R J. Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004; 18: 719–736
   PubMedGoogle Scholar
• Evans D J, Hoffmann R G, Kalkhoff R K, Kissebah A H. Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism 1984; 33: 68–75
   PubMed Web of Science ®Google Scholar
• Krotkiewski M, Seidell J C, Bjorntorp P. Glucose tolerance and hyperinsulinaemia in obese women: role of adipose tissue distribution, muscle fibre characteristics and androgens. J Intern Med 1990; 228: 385–392
   PubMedGoogle Scholar
• Ivandic A, Prpic-Krizevac I, Sucic M, Juric M. Hyperinsulinemia and sex hormones in healthy premenopausal women: relative contribution of obesity, obesity type, and duration of obesity. Metabolism 1998; 47: 13–19
   Google Scholar
• Ohlson L O, Larsson B, Svardsudd K, Welin L, Eriksson H, Wilhelmsen L, Bjorntorp P, Tibblin G. The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 1985; 34: 1055–1058
   PubMed Web of Science ®Google Scholar
• Dagenais G R, Auger P, Bogaty P, Gerstein H, Lonn E, Yi Q, Yusuf S. HOPE Study Investigators. Increased occurrence of diabetes in people with ischemic cardiovascular disease and general and abdominal obesity. Can J Cardiol 2003; 19: 1387–1391
   PubMed Web of Science ®Google Scholar
• Tan T T, Lui S K, Satgunasingam N, Khalid B A. Clinical and endocrine profiles of 62 Malaysian women with polycystic ovary syndrome. Med J Malaysia 1989; 44: 302–306
   PubMedGoogle Scholar